Medical Marijuana, Recreational Cannabis, and Cardiovascular Health
Published: August 05, 2020
- With expanding legalization of medical and recreational use of cannabis, or marijuana, at the state level in the United States, and recreational use nationally in Canada and Uruguay, the consumption of cannabis products is increasing, particularly among youth.
- These shifts in cannabis use require clinicians to understand conflicting laws, health implications, and therapeutic possibilities.
- This statement critically reviews medicinal and recreational cannabis use from clinical, policy and public health perspectives, evaluating its safety and efficacy, particularly in relationship to cardiovascular health.
Supporting Materials
- Commentary: Medical and Recreational Marijuana: Implications for Cardiovascular Health and Public Health by Ersilia M. DeFilippis, MD and Deepak L. Bhatt MD, MPH
- Top Things to Know: Medical Marijuana, Recreational Cannabis, and Cardiovascular Health
- AHA News: Heart risks of marijuana use need more research
- News Release: Cannabis use shows substantial risks, no benefits for cardiovascular health; more research is critical
Recommended Reading
- 2019 New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention
- 2014 Electronic Cigarettes
- 2019 Marijuana Use Among Young Adults (18–44 Years of Age) and Risk of Stroke
- 2014 Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders